Clinical trial
Determination of the Frequency of BRG1 and BRM Loss in Rhabdoid Tumors
NCT01553175 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of the Frequency of BRG1 and BRM Loss in Rhabdoid Tumors
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- Not reported
- Enrollment
- 25 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
brain and central nervous system tumors, kidney cancer